Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Scharf

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Case Reports in Critical Care|October 15, 2021
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine StormAlice-Christin Acevedo, Michael Zoller, Christina Scharf, et al.
Infection|September 4, 2020
Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patientsInes Schroeder, Karl Dichtl, Uwe Liebchen, et al.
Scientific Reports|August 27, 2021
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation studyUwe Liebchen, Hanna Salletmeier, Simon Kallee, et al.
Annals of Intensive Care|July 22, 2021
Can the cytokine adsorber CytoSorb<sup>®</sup> help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysisChristina Scharf, Ines Schroeder, Michael Paal, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2019
Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serumCarina Schuster, Michael Paal, Johanna Lindner, et al.
BMC Nephrology|March 15, 2024
Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysisJonathan de Fallois, Robert Scharm, Tom H Lindner, et al.
International Journal of Antimicrobial Agents|June 24, 2019
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysisLisa Ehmann, Michael Zoller, Iris K Minichmayr, et al.
Scientific Reports|May 14, 2021
Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot studyChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Critical Care (London, England)|January 29, 2021
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysisChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Blood Purification|October 11, 2023
Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with HyperbilirubinemiaCaroline Gräfe, Michael Paal, Martin Winkels, et al.
Case Reports in Critical Care|October 15, 2021
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine StormAlice-Christin Acevedo, Michael Zoller, Christina Scharf, et al.
Infection|September 4, 2020
Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patientsInes Schroeder, Karl Dichtl, Uwe Liebchen, et al.
Scientific Reports|August 27, 2021
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation studyUwe Liebchen, Hanna Salletmeier, Simon Kallee, et al.
Annals of Intensive Care|July 22, 2021
Can the cytokine adsorber CytoSorb<sup>®</sup> help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysisChristina Scharf, Ines Schroeder, Michael Paal, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2019
Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serumCarina Schuster, Michael Paal, Johanna Lindner, et al.
BMC Nephrology|March 15, 2024
Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysisJonathan de Fallois, Robert Scharm, Tom H Lindner, et al.
International Journal of Antimicrobial Agents|June 24, 2019
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysisLisa Ehmann, Michael Zoller, Iris K Minichmayr, et al.
Scientific Reports|May 14, 2021
Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot studyChristina Scharf, Uwe Liebchen, Michael Paal, et al.
Pageof 8